Syndax Pharmaceuticals
SNDX
SNDX
139 hedge funds and large institutions have $1.39B invested in Syndax Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
37% more capital invested
Capital invested by funds: $1.02B → $1.39B (+$373M)
15% more funds holding
Funds holding: 121 → 139 (+18)
7.66% more ownership
Funds ownership: 98.21% → 105.87% (+7.7%)
Holders
139
Holding in Top 10
10
Calls
$5.43M
Puts
$442K
Top Buyers
| 1 | +$39.6M | |
| 2 | +$28.4M | |
| 3 | +$19M | |
| 4 |
CC
Commodore Capital
New York
|
+$17.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$17M |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$21.4M | |
| 3 | -$13.4M | |
| 4 |
6CM
683 Capital Management
New York
|
-$10.9M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$10.1M |